Literature DB >> 1322107

Characterization of CGRP1 and CGRP2 receptor subtypes.

R Quirion1, D Van Rossum, Y Dumont, S St-Pierre, A Fournier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1322107     DOI： 10.1111/j.1749-6632.1992.tb22759.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  20 in total

1.  Receptors mediating CGRP-induced relaxation in the rat isolated thoracic aorta and porcine isolated coronary artery differentiated by h(alpha) CGRP(8-37).

Authors:  F M Wisskirchen; D W Gray; I Marshall
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

2.  Characterization of receptors for calcitonin gene-related peptide and adrenomedullin on the guinea-pig vas deferens.

Authors:  D R Poyner; G M Taylor; A E Tomlinson; A G Richardson; D M Smith
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

3.  Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists.

Authors:  K J Powell; W Ma; M Sutak; H Doods; R Quirion; K Jhamandas
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

Review 4.  Chemical mediators of migraine: preclinical and clinical observations.

Authors:  Saurabh Gupta; Stephanie J Nahas; B Lee Peterlin
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

5.  CGRP(2) receptor in the internal anal sphincter of the rat: implications for CGRP receptor classification.

Authors:  F M Wisskirchen; I Marshall
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

6.  Conformational restraints revealing bioactive beta-bend structures for halpha CGRP8-37 at the CGRP2 receptor of the rat prostatic vas deferens.

Authors:  F M Wisskirchen; P M Doyle; S L Gough; C J Harris; I Marshall
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

7.  Pharmacology.

Authors:  Hayrunnisa Bolay; Paul Durham
Journal:  Handb Clin Neurol       Date:  2010

Review 8.  Current and prospective pharmacological targets in relation to antimigraine action.

Authors:  Suneet Mehrotra; Saurabh Gupta; Kayi Y Chan; Carlos M Villalón; David Centurión; Pramod R Saxena; Antoinette MaassenVanDenBrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-15       Impact factor: 3.000

9.  Noncompetitive antagonism of BIBN4096BS on CGRP-induced responses in human subcutaneous arteries.

Authors:  Majid Sheykhzade; Henrik Lind; Lars Edvinsson
Journal:  Br J Pharmacol       Date:  2004-10-11       Impact factor: 8.739

Review 10.  Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells.

Authors:  Silvia Di Angelantonio; Rashid Giniatullin; Valeria Costa; Elena Sokolova; Andrea Nistri
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.